Glucose Health, Inc. GLUC
OTC · stock · Medicinal Chemicals & Botanical Products · website · IPO 2008-07-11
Glucose Health, Inc. financials (annual, from 10-K)
Bars are annual figures from 2011 to 2016; red bars are negative (a loss or cash outflow).
| Metric | FY2016 | FY2015 | FY2014 | FY2014 | FY2013 | FY2013 | FY2013 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross profit | $19,167 | $397 | -$20,726 | -$6,676 | -$2,091 | -$16,483 | -$3,632 | -$3,632 | -$3,632 | — |
| R&D expense | — | $48 | $4,000 | — | — | — | — | — | — | — |
| Operating income | -$86,647 | -$156,173 | -$545,216 | -$1.8M | -$1.3M | -$1.2M | -$1.0M | -$724,986 | -$361,423 | -$888,812 |
| Interest expense | $323,796 | $120,028 | $109,631 | $211,506 | $168,862 | $30,936 | $138,428 | $79,360 | $37,655 | $10,374 |
| Net income | -$410,443 | -$266,064 | -$669,409 | -$2.1M | -$1.5M | -$1.3M | -$1.1M | -$804,346 | -$399,078 | -$899,186 |
| Operating cash flow | -$39,263 | -$115,776 | -$135,352 | -$221,386 | -$131,985 | -$213,119 | -$186,876 | -$138,992 | -$83,691 | -$23,302 |
| Cash & equivalents | $20,542 | $2,055 | $4,871 | — | $711 | — | — | — | $1,076 | $82 |
| Inventory | — | $8,370 | $0 | $23,676 | $24,879 | $27,904 | $43,903 | — | — | — |
| Total assets | $33,145 | $15,407 | $44,030 | $23,676 | $25,590 | $464,732 | $492,016 | $250,088 | $207,676 | $233,682 |
| Total liabilities | $528,592 | $403,226 | $324,582 | $220,467 | $223,348 | $242,449 | $234,699 | $358,442 | $185,476 | $419,704 |
| Shareholders' equity | -$495,447 | -$387,819 | -$280,552 | -$196,791 | -$197,758 | $222,283 | $257,317 | -$108,354 | $22,200 | -$186,022 |
Source: SEC EDGAR filings · CIK 0001420108 · US · as of 2016-12-31. facts plus Stocktoria's own computed scores — not investment advice.